Skip to main content
# Title Department Research Member Research Year
21 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Department of Medical Oncology Dr. Ahmed Mubarak Hefni Ismail 2025
22 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2025
23 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2025
24 Exploring the efficacy of various wheat bran extracts in promoting burn wound healing: A comparative analysis Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2024
25 Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study Department of Radiotherapy and Nuclear medicine Dr. Esraa Roshdy Hassan Mohamed 2024
26 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Hadeer Mohamed Saad Elshazly 2024
27 Pediatric cancer mortality: Analyzing early deaths and fatalities in a resource-limited tertiary care context Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2024
28 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024
29 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2024
30 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Department of Medical Oncology Samar Abotaleb Mahmou 2024